Insiders · Profile

Tubridy Karen L

SVP, Chief Development Officer at Akebia Therapeutics. Filing since 28 Feb 2020. CIK 0001589888

Company

Date

Role

Action

Amount

Of holding

28 Feb 2020

SVP, Chief Development Officer

Sold, plan not stated

3,454

$30.05K

3.9%

1 decision on file.